Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Outer membrane vesicles displaying engineered glycotopes elicit protective antibodies

Journal Article · · Proceedings of the National Academy of Sciences of the United States of America
 [1];  [1];  [1];  [1];  [1];  [2];  [3];  [4];  [5];  [6];  [6];  [6];  [6];  [7];  [4];  [8];  [7]
  1. Robert Frederick Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY 14853,
  2. Department of Microbiology, University of Iowa, Iowa City, IA 52242,
  3. Genetics Program, University of Iowa, Iowa City, IA 52242,
  4. Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712,, Department of Infectious Diseases, The University of Georgia College of Veterinary Medicine, Athens, GA 30602,
  5. Nancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853,
  6. Complex Carbohydrate Research Center, The University of Georgia, Athens, GA 30602
  7. Robert Frederick Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY 14853,, Nancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853,
  8. Department of Microbiology, University of Iowa, Iowa City, IA 52242,, Genetics Program, University of Iowa, Iowa City, IA 52242,

Significance

Conjugate vaccines have proven to be an effective and safe strategy for reducing the incidence of disease caused by bacterial pathogens. However, the manufacture of these vaccines is technically demanding, inefficient, and expensive, thereby limiting their widespread use. Here, we describe an alternative methodology for generating glycoconjugate vaccines whereby recombinant polysaccharide biosynthesis is coordinated with vesicle formation in nonpathogenic Escherichia coli , resulting in glycosylated outer membrane vesicles (glycOMVs) that can effectively deliver pathogen-mimetic glycotopes to the immune system. An attractive feature of our approach is the fact that different plasmid-encoded polysaccharide biosynthetic pathways can be readily transformed into E. coli , enabling a “plug-and-play” platform for the on-demand creation of glycOMV vaccine candidates that carry heterologous glycotopes from numerous pathogenic bacteria.

Sponsoring Organization:
USDOE
Grant/Contract Number:
FG02-93ER20097
OSTI ID:
1256136
Alternate ID(s):
OSTI ID: 1349046
Journal Information:
Proceedings of the National Academy of Sciences of the United States of America, Journal Name: Proceedings of the National Academy of Sciences of the United States of America Journal Issue: 26 Vol. 113; ISSN 0027-8424
Publisher:
Proceedings of the National Academy of SciencesCopyright Statement
Country of Publication:
United States
Language:
English

References (62)

A systematic nomenclature for carbohydrate fragmentations in FAB-MS/MS spectra of glycoconjugates journal January 1988
Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant journal August 2008
Somatic antigens of Shigella: Structure of the O-specific polysaccharide chain of the Shigella dysenteriae type 7 lipopolysaccharide journal August 1988
Structure of the O-antigen of Francisella tularensis strain 15 journal July 1991
Role of lipopolysaccharide and a major outer membrane protein from Francisella tularensis in the induction of immunity against tularemia journal January 1995
Expression cloning of Yersinia enterocolitica 0 : 3 rfb gene cluster in Escherichia coli K12 journal January 1991
Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis journal August 2001
Immunology of bacterial polysaccharide antigens journal November 2003
Microbial biosynthesis of designer outer membrane vesicles journal October 2014
Engineered Bacterial Outer Membrane Vesicles with Enhanced Functionality journal June 2008
Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae journal August 2008
Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis journal June 2009
Preparation of bacterial polysaccharide–protein conjugates: Analytical and manufacturing challenges journal October 2009
B Cell Mitogenic Properties of Thymus-independent Antigens journal September 1973
Innate B cell helpers reveal novel types of antibody responses journal January 2013
Carbohydrate vaccines: developing sweet solutions to sticky situations? journal April 2010
New vaccine platform? journal March 2010
T-cell–B-cell cooperation journal April 2004
Tularaemia: bioterrorism defence renews interest in Francisella tularensis journal December 2004
Characterization of bacteria using its O-antigen with surface-enhanced Raman scattering journal January 2010
Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in Escherichia coli journal February 2005
Substrate specificity of bacterial oligosaccharyltransferase suggests a common transfer mechanism for the bacterial and eukaryotic systems journal April 2006
Delivery of foreign antigens by engineered outer membrane vesicle vaccines journal January 2010
Modulating the innate immune response by combinatorial engineering of endotoxin journal January 2013
Incorporation of Heterologous Outer Membrane and Periplasmic Proteins into Escherichia coli Outer Membrane Vesicles journal October 2003
γδ T Cells Provide an Early Source of Interferon γ in Tumor Immunity journal August 2003
Exploitation of bacterial N -linked glycosylation to develop a novel recombinant glycoconjugate vaccine against Francisella tularensis journal May 2013
Recent developments in bacterial protein glycan coupling technology and glycoconjugate vaccine design journal April 2012
Characterization of the O antigen gene cluster and structural analysis of the O antigen of Francisella tularensis subsp. tularensis journal October 2003
Protective B-cell epitopes of Francisella tularensis O-polysaccharide in a mouse model of respiratory tularaemia: Protective epitopes of Francisella tularensis O-antigen journal June 2012
Release of the type I secreted alpha-haemolysin via outer membrane vesicles from Escherichia coli journal January 2006
Elucidation of a novel Vibrio cholerae lipid A secondary hydroxy-acyltransferase and its role in innate immune recognition: Incorporation of hydroxy fatty acids into V. cholerae LPS by LpxN journal July 2011
Production of Secretory and Extracellular N-Linked Glycoproteins in Escherichia coli journal December 2010
Successful Protection against Tularemia in C57BL/6 Mice Is Correlated with Expansion of Francisella tularensis-Specific Effector T Cells journal November 2014
Naturally Produced Outer Membrane Vesicles from Pseudomonas aeruginosa Elicit a Potent Innate Immune Response via Combined Sensing of Both Lipopolysaccharide and Protein Components journal July 2010
Immunization with Salmonella enterica Serovar Typhimurium-Derived Outer Membrane Vesicles Delivering the Pneumococcal Protein PspA Confers Protection against Challenge with Streptococcus pneumoniae journal November 2010
Inactivated Francisella tularensis Live Vaccine Strain Protects against Respiratory Tularemia by Intranasal Vaccination in an Immunoglobulin A-Dependent Fashion journal February 2007
Francisella tularensis Schu S4 Lipopolysaccharide Core Sugar and O-Antigen Mutants Are Attenuated in a Mouse Model of Tularemia journal January 2014
Immunologic Memory Induced by a Glycoconjugate Vaccine in a Murine Adoptive Lymphocyte Transfer Model journal May 1998
Cognate Stimulatory B-Cell–T-Cell Interactions Are Critical for T-Cell Help Recruited by Glycoconjugate Vaccines journal December 1999
Purified Lipopolysaccharide from Francisella tularensis Live Vaccine Strain (LVS) Induces Protective Immunity against LVS Infection That Requires B Cells and Gamma Interferon journal April 2000
Expression of Heterologous Antigens in Commensal Neisseria spp.: Preservation of Conformational Epitopes with Vaccine Potential journal October 2004
Escherichia coli tol-pal Mutants Form Outer Membrane Vesicles journal September 1998
Working toward the Future: Insights into Francisella tularensis Pathogenesis and Vaccine Development journal November 2009
Pathogenicity and molecular genetics of O-specific side-chain lipopolysaccharides of Escherichia coli journal July 1992
How Bacterial Carbohydrates Influence the Adaptive Immune System journal March 2010
Lipopolysaccharide Endotoxins journal June 2002
Biosynthesis and Assembly of Capsular Polysaccharides in Escherichia coli journal June 2006
T Cell-Independent Antigens Type 2 journal April 1995
Biological Functions and Biogenesis of Secreted Bacterial Outer Membrane Vesicles journal October 2010
Production of glycoprotein vaccines in Escherichia coli journal January 2010
Discovery of new biosynthetic pathways: the lipid A story journal October 2008
Identification, Characterization and Immunogenicity of an O-Antigen Capsular Polysaccharide of Francisella tularensis journal July 2010
Mechanistic Insight into the TH1-Biased Immune Response to Recombinant Subunit Vaccines Delivered by Probiotic Bacteria-Derived Outer Membrane Vesicles journal November 2014
Conjugate vaccines journal October 2003
Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines journal March 2011
Vaccines based on the cell surface carbohydrates of pathogenic bacteria journal June 2005
Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro journal January 2013
Antibody-mediated immunity induced by engineered Escherichia coli OMVs carrying heterologous antigens in their lumen journal January 2014
A Novel Role for Plasmin-Mediated Degradation of Opsonizing Antibody in the Evasion of Host Immunity by Virulent, but Not Attenuated, Francisella tularensis journal September 2009
Membrane Vesicles Are Immunogenic Facsimiles of Salmonella typhimurium That Potently Activate Dendritic Cells, Prime B and T Cell Responses, and Stimulate Protective Immunity In Vivo journal November 2007
Bexsero: A multicomponent vaccine for prevention of meningococcal disease journal February 2012

Similar Records

Related Subjects